retatrutide and gallbladder experimental weight-loss drug side effects concerns Retatrutide Contraindications: Risks and Considerations
Description
3-5 In monotherapy, no other oral treatment class has significantly shown higher efficacy in lowering HbA1c
Casey Dean, DO Board-Certified Family Medicine Physician Dr
Regulatory Context Research Procurement Status Retatrutide is an investigational new drug not approved by the FDA for human use
The protocols were approved by the North West 1 Research Ethics Committee (registration number: 10/H0717/32) (Clinical trial number: NCT01841073) and conformed to the Declaration of Helsinki
